Arvinas paid its 5 named executives $17.7M in total in FY2025 (Dec).
Pay of each named executive
John Houston, Ph.D.Former President and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Noah Berkowitz, M.D., Ph.D.Chief Medical Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed |
2 years
Andrew SaikChief Financial Officer and Treasurer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed |
2 years
Angela Cacace, Ph.D.Chief Scientific Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) |
2 years
Ian Taylor, Ph.D.Former President of Research and Development
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 5 peers with pay on file was $5.1M. The CEO of Arvinas was paid $6.5M, 29% above the median.
- 1Cogent Biosciences
- 2Arcus Biosciences
- 3ArvinasThis company
- 4Intellia Therapeutics
- 5Relay Therapeutics
- 6Regenxbio
- 7Alector, Inc.Not disclosed
- 8Arrowhead PharmaceuticalsNot disclosed
- 9BiohavenNot disclosed
- 10Crinetics Pharmaceuticals, Inc.Not disclosed
- 11Denali Pharmaceuticals, Inc.Not disclosed
- 12ErascaNot disclosed
- 13KalVista Pharmaceuticals, Inc. ()Not disclosed
- 14Prothena Corporation plc ()Not disclosed
- 15SpringWorks Therapeutics, Inc.Not disclosed
- 16Syndax PharmaceuticalsNot disclosed
- 17XencorNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.